Compare SPDR Gold Trust (GLD) vs Humana Inc (HUM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SPDR Gold Trust vs Humana Inc — how do they compare? SPDR Gold Trust trades at $384.4 (market cap $139.66B), while Humana Inc trades at $433 (market cap $46.49B). The key difference: SPDR Gold Trust is far larger — about 3× Humana Inc's market cap, and Humana Inc pays a 0.91% dividend while SPDR Gold Trust pays none. Which is the better fit depends on your goals — on Pluang, investors hold SPDR Gold Trust for 74 Days and Humana Inc for 51 Days on average.
| GLD | HUM | |
|---|---|---|
Market Cap | $139.66B | $46.49B |
Volume | 9,544,773 | 2,567,704 |
52-Week High | $495.90 | $409.85 |
52-Week Low | $362.32 | $163.67 |
Typical Hold Time | 74 Days | 51 Days |
Sector | — | Health |
Enterprise Value | — | $53.84B |
Dividend Yield | — | 0.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GLD trades at $384.58, up 2.31% with bearish technical signals dominating. The ETF faces pressure from rising Treasury yields and a strong dollar, with technical indicators showing 17 sell signals versus 2 buy signals. Recent news highlights gold's struggle to maintain momentum despite safe-haven demand, with prices testing key support levels amid Federal Reserve policy uncertainty.
The outlook remains cautious as elevated yields and dollar strength create headwinds, though some analysts see tactical opportunities near current levels. Key risks include further Fed tightening and bond market volatility, while potential catalysts include geopolitical tensions and inflation concerns. The technical setup suggests continued pressure with support at $377-$374.
Humana (HUM) trades at $431.03, up 8.71% over the past day, reflecting strong momentum following a Barclays upgrade and positive earnings beats. The stock exhibits a bullish technical trend, with support at $378 and resistance at $394. Revenue has grown steadily from $92.9B in 2022 to $129.7B in 2025, though net income margins have compressed to 0.88%. Analyst consensus is a Buy with a $457.05 price target, and recent news highlights corporate initiatives and institutional investments.
The outlook for HUM is cautiously optimistic, driven by revenue growth and analyst support, but risks include margin pressure and regulatory scrutiny. Investment opportunity lies in execution of Medicare Advantage strategies, while key risks involve competitive pressures and potential fiduciary concerns highlighted in recent shareholder notices.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SPDR Gold Trust
GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.
Read more on GLD →About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →
